RVMDRevolution Medicines, Inc.

$215.57

Who owns RVMD

503 institutions reported holding RVMD for 2026Q1, together 100% of the company, more than the 380 a quarter earlier.

503

Institutions reporting a position · as of 2026Q1 · up from 380 the quarter before

Shares held by institutions
198.2M

Shares held by institutions · 100% of the company · long US equity positions only, as reported on Form 13F

Reported value
$19.0B

Reported value · at 2026-03-31 prices, not today's

Top 5 holders
31%

Top 5 holders · of the whole company, between five filers

Details
Reporting quarter2026-03-31
2026Q1
Quarters on record
25
New positions
162
Positions exited
43
Added to
154
Reduced
123
Top 10 holdersof the company
48%
Institutional ownership by quarter, 2020Q1 to 2026Q1
QuarterFilersSharesReported value
2026Q1503198.2M$19.0B
2025Q4380199.3M$15.9B
2025Q3319191.8M$8.95B
2025Q2304190.7M$7.02B
2025Q1279192.4M$6.82B
2024Q4278192.9M$8.44B
2024Q3250170.5M$7.73B
2024Q2221168.3M$6.53B
2024Q1209160.6M$5.18B
2023Q4183159.9M$4.59B
2023Q3166112.3M$3.11B
2023Q2138112.0M$2.99B
2023Q1150108.1M$2.34B
2022Q413588.2M$2.10B
2022Q314188.4M$1.74B
2022Q213476.5M$1.49B
Largest reported holders, 2026Q1
HolderShares% of companyValue
VANGUARD GROUP INC17.2M8.7%$1.68B
FARALLON CAPITAL MANAGEMENT LLC13.6M6.9%$1.32B
BlackRock Inc.11.2M5.7%$1.09B
HENDERSON GROUP PLC9.8M4.9%$950M
BAKER BROS. ADVISORS LP9.6M4.8%$929M
FMR LLC8.5M4.3%$823M
Nextech Invest, Ltd.7.6M3.8%$739M
Paradigm Biocapital Advisors LP6.7M3.4%$647M
WELLINGTON MANAGEMENT GROUP LLP6.0M3.0%$586M
ADAGE CAPITAL PARTNERS GP, L.L.C.5.5M2.8%$533M

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.

reading the register…